“The bottom line is that if you have a higher matching score, which is you have more mutations with drugs targeted to them, you get
“Be honest with yourself, and be honest with your providers about symptoms you’re having. If a bone hurts, please tell somebody about it. If you’re
Meeting Summary Peter Kuhn, PhD, Dean’s Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, Aerospace & Mechanical Engineering, and Urology, University of Southern
Meeting Summary “I want to use the biopsy of my tumor tissue to do a couple things: (1) to make sure that I get greater
Meeting Summary How can physicians be convinced to overcome concerns of safety, reimbursement, and liability to prescribe novel regimens (personalized drug combinations, dosing, and sequences),
Meeting Summary Advanced cancer patient Brian McCloskey shared the 17 treatment options that have been identified for him by various sources, including Cancer Commons/xCures, CureMatch, and Massive
Meeting Summary Tony Letai, MD, PhD, Professor at Dana Farber Cancer Institute, and President, Society for Functional Precision Medicine, led a discussion on “Functional Precision
The Personalized Medicine Coalition (PMC), in their May 2022 newsletter, highlights Brad Power and the CancerHacker Lab’s initiative to focus on Advanced Prostate Cancer patients.
The Harvard Medical School published an article and a very moving video about Linnea Olson. Check it out here: https://executiveeducation.hms.harvard.edu/linnea-olson-appreciation
In this episode, Libbi Rickenbacher of 4G Clinical’s Trial Trends podcast is joined by Brad Power, Founder of CancerHacker Lab, to discuss what can be done
© 2021 CancerHacker Lab. All rights reserved
Disclaimer | Privacy Policy | DESIGNED BY HEARTFELT BUSINESS MEDIA
Recent Comments